Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: Role of interleukin-6 and disease duration

Circulation

Volumn 107, Issue 25, 2003, Pages 3199-3203

  Davì, Giovanni ^a   Chiarelli, Francesco ^a   Santilli, Francesca ^a   Pomilio, Mariapina ^a   Vigneri, Sergio ^b   Falco, Angela ^a   Basili, Stefania ^c   Ciabattoni, Giovanni ^a   Patrono, Carlo ^c  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Diabetes mellitus; Inflammation; Platelets

Indexed keywords

11 OXOTHROMBOXANE B2; 8 ISOPROSTAGLANDIN F2 ALPHA; C REACTIVE PROTEIN; INTERLEUKIN 6; ISOPROSTANE; LIPID; THROMBOXANE A2; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC ANGIOPATHY; DIABETOGENESIS; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTE ACTIVATION;

ADOLESCENT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DINOPROST; DISEASE PROGRESSION; F2-ISOPROSTANES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INSULIN; INTERLEUKIN-6; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PLATELET ACTIVATION; REFERENCE VALUES; THROMBOXANE A2; THROMBOXANE B2; TIME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038755593     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000074205.17807.D0     Document Type: Article

References (33)

1. Danne T, Kordonouri O, Hövener C, et al. Diabetic angiopathy in children. Diabetic Med. 1997;14:1012-1025.
2. Palinski W, Witzum JL. Oxidative stress and diabetes mellitus. In: Schwartz CJ, Born GVR, eds. New Horizons in Diabetes Mellitus and Cardiovascular Disease. London, UK: Rapid Science Publishers; 1996: 81-93.
3. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20:707-727.
4. Chisolm GM, Irwin KC, Penn MS. Lipoprotein oxidation and lipoprotein-induced injury in diabetes. Diabetes. 1992;4:61-66.
5. Tsai EC, Hirsch IB, Brunzell JD, et al. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes. 1994;43:1010-1014.
6. Nishigaki I, Hagihara M, Tsunekawa et al. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med. 1981;25:373-378.
7. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, et al. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes. 1995;44:1054-1058.
8. 2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 1999;99:224-229.
9. Patrono C, FitzGerald GA. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol. 1997;17:2309-2315.
10. 2α is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1997;17:3230-3235.
11. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203.
12. Reilly M, Delanty N, Lawson JA, et al. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation. 1996;94:19-25.
13. Davì G, Di Minno G, Coppola A, et al. Oxidative stress and platelet activation in homozygous homocystinuria. Circulation. 2001;104:1124-1128.
14. Minuz P, Patrignani P, Gaino S, et al. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation. 2002;106:2800-2805.
15. Ciabattoni G, Davì G, Collura M, et al. In vivo lipid peroxidation and platelet activation in cystic fibrosis. Am J Respir Crit Care Med. 2000;162:1195-1201.
16. Davì G, Guagnano MT, Ciabattoni G, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA. 2002;288:2008-2014.
17. Roberts CK, Vaziri ND, Barnard J. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation. 2002;106:2530-2532.
18. 2α is not mediated by thromboxane receptor isoforms. J Biol Chem. 1996;271:14916-14924.
19. Minuz P, Andrioli G, Degan M, et al. The F2-isoprostane 8-epiprostaglandin F2 alpha increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol. 1998;18:1248-1256.
20. Davì G, Catalano I, Averna M, et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med. 1990;322:1769-1774.
21. Hanninen A, Jalkanen S, Salmi M, et al. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of IDDM. J Clin Invest. 1992;90:1901-1910.
22. Harrison LC, Honeyman MC, De Aizpurua HJ. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of IDDM. Lancet. 1993;341:1365-1369.
23. Hussain MJ, Peakman M, Gallati H, et al. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia. 1996;39:60-69.
24. Targher G, Zenari L, Bertolini L, et al. Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications. Diabetes Care. 2001;24:956-957.
25. Erbagci AB, Tarakcioglu M, Coskun Y, et al. Mediators of inflammation in children with type 1 diabetes mellitus: cytokines in type 1 diabetic children. Clin Biochem. 2001;34:645-650.
26. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28: 1039-1057.
27. Ledue TB, Weiner DL, Sipe JD, et al. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem. 1998;35:745-753.
28. Makita Z, Vlassara H, Cerami A, et al. Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem. 1992;267:5133-5138.
29. Khuu HM, Robinson CA, Goolsby K, et al. Evaluation of a fully automated high-performance liquid chromatography assay for hemoglobin Alc. Arch Pathol Lab Med. 1999;123:763-767.
30. 2α excretion in man. J Pharmacol Exp Ther. 1995;275:94-100.
31. 2 in human plasma and urine. Biochim Biophys Acta. 1987;918:29-37.
32. Zhang J, Johnston G, Stebler B, et al. Hydrogen peroxide activates NFkappaB and the interleukin-6 promoter through NFkappaB-inducing kinase. Antioxidant Redox Signal. 2001;3:493-504.
33. Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol. 2001;115:3-12.